Steroid maker sold other drugs in MN
A Massachusetts company at the center of a deadly meningitis outbreak was selling medications to some of the largest medical groups in Minnesota even though it had no license to do so, the Star Tribune has learned. The New England Compounding Center, which is under investigation for selling tainted steroids, has supplied a host of other drugs to the Mayo Clinic, Allina, HealthPartners and other hospitals and clinics—many more than previously disclosed—officials confirmed in interviews. Questions are surfacing about the company's sales practices as it went around the country marketing hundreds of drugs to hospitals and clinics even though it was not subject to the strict federal safety rules that apply to drug manufacturers.
- Senators Hear How Two-Midnight Rule Harms Patients, Hospitals
- 3 Management Lessons from a Supermarket Debacle
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts
- Physicians to Appeal 'Docs v. Glocks' Ruling in FL
- IOM Identifies GME Problems, Calls for Finance Changes
- Healthcare Costs Start With What We Eat
- Handshaking Spreads Germs. Get Over It.
- Revenue Cycles Get a Boost from Simple JPEG Files
- Hospitals Likely to Outsource ICD-10 at Launch
- Anatomy of 3 Health System Rebranding Efforts